𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sorafenib before liver transplantation for hepatocellular carcinoma: risk or give up

✍ Scribed by Fabrizio Di Benedetto; Giuseppe Tarantino; Roberto Montalti; Roberto Ballarin; Giuseppe D’Amico; Massimiliano Berretta; Giorgio Enrico Gerunda

Book ID
110917657
Publisher
Springer
Year
2011
Tongue
English
Weight
129 KB
Volume
24
Category
Article
ISSN
0934-0874

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatocellular carcinoma: Sorafenib befo
Hepatocellular carcinoma: Sorafenib before liver transplantation?
✍ Alain Braillon 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 495 KB 👁 1 views

This study was partially supported by grants UBACYT M055 (Universidad de Buenos Aires) and PICT 06-124 (Agencia Nacional de Promocio´n Cien-tı´fica y Tecnolo´gica).

Sorafenib therapy in patients with hepat
Sorafenib therapy in patients with hepatocellular carcinoma before liver transplantation
✍ Ian A. Rowe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB 👁 1 views

The team of Liu et al. generated endoderm-derived human induced pluripotent stem (iPS) cells from primary hepatocytes. 1 However, they generated human iPS cells by using viral transgenes. 1 Clinical applications of human iPS cells require avoiding viral transgenes. On the other hand, the reprogrammi